Kazakhstan intensifies pharmaceutical purchases to treat COVID-19

NUR-SULTAN. KAZINFORM – Acquisition of prescription drugs for the COVID-19 remedy to accumulate a two-month reserve has intensified in Kazakhstan, reports the Kazinform correspondent.

According to Yerkhat Iskaliyev, chairman of the SK-Pharmacy board, 50 high-demand prescription drugs worth 24 billion tenge are being purchased.Prescription drugs would last two months and treat 100,000 patients in a month for a imaginable wave of COVID-19.

Iskaliyev also spoke about five new prescription drugs that were added to treat the COVID-19 virus in patients with mild and moderate symptoms. They come with prescription anti-inflammatory drugs like acetaminophen, ibuprofen, as well as the blood thinners Rivaroxaban, Apixaban, and Dabigatran.

Leave a Comment

Your email address will not be published. Required fields are marked *